The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

14426–14450 of 17799

  • SevereFDA (Drugs)·D-0379-2015·2015-01-28

    Valeant Recalls Virazole Due to Microbial Contamination

    Valeant Pharmaceuticals is recalling Virazole (ribavirin) inhalation solution due to positive microbial contamination found during stability testing.

    Product
    Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0368-2015·2015-01-28

    Walgreens Recalls Ranitidine Syringes Due to Sterility Assurance Concerns

    Walgreens Infusion Services is recalling various strengths of ranitidine syringes because of a lack of sterility assurance. The products were distributed in six states.

    Product
    Ranitidine various strengths in syringes
    Category
    Drug
    Distribution
    6 states
  • SevereFDA (Drugs)·D-0356-2015·2015-01-28

    Walgreens Recalls Daptomycin Infusion Bags Due to Sterility Concerns

    Walgreens Infusion Services is recalling Daptomycin in normal saline bags due to a lack of sterility assurance. The products were distributed in six southern states.

    Product
    Daptomycin various strengths in normal saline bags
    Category
    Drug
    Distribution
    6 states
  • SevereFDA (Drugs)·D-0347-2015·2015-01-28

    Walgreens Recalls Ertapenem Infusion Bags Due to Sterility Concerns

    Walgreens Infusion Services is recalling Ertapenem in normal saline bags due to a lack of sterility assurance. The products were distributed in six states.

    Product
    Ertapenem various strength in normal saline bags
    Category
    Drug
    Distribution
    6 states
  • SevereFDA (Drugs)·D-0341-2015·2015-01-28

    Walgreens Recalls Amikacin Infusion Bags Due to Sterility Concerns

    Walgreens Infusion Services is recalling Amikacin in normal saline bags due to a lack of sterility assurance. The products were distributed in six states.

    Product
    Amikacin various strength in normal saline bags
    Category
    Drug
    Distribution
    6 states
  • SevereFDA (Drugs)·D-0344-2015·2015-01-28

    Walgreens Recalls Cefoxitin Infusion Bags Due to Sterility Concerns

    Walgreens Infusion Services is recalling Cefoxitin in normal saline bags due to a lack of sterility assurance. The products were distributed in six states.

    Product
    Cefoxitin various strength in normal saline bags
    Category
    Drug
    Distribution
    6 states
  • SevereFDA (Drugs)·D-0357-2015·2015-01-28

    Walgreens Recalls Ceftriaxone Infusions Due to Sterility Concerns

    Walgreens Infusion Services is recalling ceftriaxone in normal saline due to a lack of sterility assurance. The products were distributed in six states.

    Product
    Ceftriaxone various strengths in normal saline
    Category
    Drug
    Distribution
    6 states
  • SevereFDA (Drugs)·D-0361-2015·2015-01-28

    Acyclovir Infusion Recall Due to Lack of Sterility Assurance

    Walgreens Infusion Services is recalling Acyclovir in normal saline due to lack of sterility assurance. The products were distributed in six states.

    Product
    Acyclovir various strengths in normal saline
    Category
    Drug
    Distribution
    6 states
  • SevereFDA (Drugs)·D-0377-2015·2015-01-28

    Mylan Recalls Ciprofloxacin Tablets Due to Manufacturing Deviations

    Mylan Institutional, Inc. is recalling Ciprofloxacin Tablets 500 mg because they were produced with active ingredients not manufactured according to Good Manufacturing Practices.

    Product
    CIPROFLOXACIN TABLETS, USP, 500 mg, 100 Tablets (10 tablets per blister card. 10 blister cards per carton), Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 51079-182-20.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0370-2015·2015-01-28

    Walgreens Recalls Deferoxamine Infusions Due to Sterility Concerns

    Walgreens Infusion Services is recalling Deferoxamine in normal saline due to a lack of sterility assurance. The products were distributed in six states.

    Product
    Deferoxamine various strengths in normal saline
    Category
    Drug
    Distribution
    6 states
  • ModerateFDA (Drugs)·D-0378-2015·2015-01-28

    Mylan Lamotrigine Tablets Recalled for CGMP Deviations

    Mylan Institutional is recalling 3,993 cartons of Lamotrigine 200 mg tablets because they were not manufactured according to Good Manufacturing Practices.

    Product
    LAMOTRIGINE TABLETS, 200 mg, 100 Tablets (10 tablets per blister card x 10 blister cards per carton), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 51079-866-20
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0376-2015·2015-01-28

    3M ESPE Clinpro 5000 Toothpaste Recalled for Missing Lot and Expiration Dates

    3M ESPE is recalling 19,728 tubes of Clinpro 5000 Anti-Cavity Toothpaste because the primary boxes are missing lot numbers and expiration dates.

    Product
    3M ESPE Clinpro 5000 (1.1% Sodium Flouride), Anti-Cavity Toothpaste, 4 oz tube (NDC 48878-3130-04), Rx Only, Manufactured for 3M ESPE Dental Products, St. Paul, MN 55144
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0339-2015·2015-01-21

    SCA Pharmaceuticals Recalls Glycopyrrolate Injection Due to Labeling Error

    SCA Pharmaceuticals is recalling 972 syringes of Glycopyrrolate injection distributed in Louisiana because a printing error made the expiration date appear incorrect.

    Product
    Glycopyrrolate injection, 0.2 mg per mL (1 mg/5 mL), 5 mL Fill in 10 mL Syringe, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205, 877-550-5059
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0334-2015·2015-01-14

    Hospira Recalls 0.9% Sodium Chloride Injection Due to Sterility Concerns

    Hospira Inc. is recalling 30,840 bags of 0.9% Sodium Chloride Injection, USP, 100mL, due to a potential leak at the administrative port that compromises sterility.

    Product
    0.9% Sodium Chloride Injection, USP, 100mL, VisIV Container, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-7984-11
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0336-2015·2015-01-14

    Actavis Recalls Gabapentin Capsules Due to Physical Defects

    Actavis Elizabeth LLC is recalling specific lots of Gabapentin 400 mg capsules distributed in Puerto Rico due to clumping, breaking, and packaging defects.

    Product
    GABAPENTIN — GABAPENTIN (GABAPENTIN)
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0331-2015·2015-01-14

    Qualitest Recalls Acetaminophen and Codeine Oral Solution Due to Impurity

    Qualitest Pharmaceuticals is recalling specific lots of Acetaminophen and Codeine Phosphate Oral Solution because they failed impurity specifications for p-Aminophenol.

    Product
    ACETAMINOPHEN and CODEINE PHOSPHATE ORAL SOLUTION USP, 120 mg/12 mg per 5 mL, packaged in a) 4 oz. (120 mL) bottles, NDC 0603-9013-54, UPC 3 0603-9013-54 8 and b) ONE PINT (473 mL) bottles, NDC 0603-9013-58, UPC 3 0603-9013-58 6, Rx only, Manufactured for: QUALITEST…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0332-2015·2015-01-14

    Par Pharmaceutical Recalls HydrALAZINE Tablets Due to Aluminum Particles

    Par Pharmaceutical is recalling one lot of HydrALAZINE Hydrochloride tablets because small aluminum particles were found in the product.

    Product
    HydrALAZINE Hydrochloride Tablets, USP 25 mg, 100 count bottle Rx only, Distributed by: Par Pharmaceutical Companies, Inc. Spring Valley, NY10977
    Category
    Drug
    Distribution
    Distributed nationwide